TEM8 ANTIBODIES AND THEIR USE Read more about TEM8 ANTIBODIES AND THEIR USE European Patent19201975.0Filed on 2019-10-08
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen Read more about Chimeric Antigen Receptors Targeting B-cell Maturation Antigen Australia2021202158Filed on 2021-04-08
Recurrence Gene Signature Across Multiple Cancer Types Read more about Recurrence Gene Signature Across Multiple Cancer Types Patent Cooperation TreatyPCT/US2019/049688Filed on 2019-09-05
Anti-Mutated Kras T Cell Receptors Read more about Anti-Mutated Kras T Cell Receptors Japan2021-063092Filed on 2021-04-01
IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN Read more about IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN Patent Cooperation TreatyPCT/US2020/057949Filed on 2020-10-29
IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Read more about IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF Patent Cooperation TreatyPCT/US2019/053825Filed on 2019-09-30
Methods for Decreasing Influenza-Induced Lethality using Gastrin-Releasing Peptide (GRP) Inhibitors or Gastrin-Releasing Peptide Receptor (GRPR) Antagonists Read more about Methods for Decreasing Influenza-Induced Lethality using Gastrin-Releasing Peptide (GRP) Inhibitors or Gastrin-Releasing Peptide Receptor (GRPR) Antagonists US Application 17/274,564Filed on 2021-03-09
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon India202118011347Filed on 2021-03-17
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2 Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2 Patent Cooperation TreatyPCT/US2021/026883Filed on 2021-04-12
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS European Patent19805442.1Filed on 2021-05-20